Dangerous and sometimes deadly infections - spread by contact and airborne modes of transmission - already existed, but COVID-19 has added a new sense of urgency and complexity to your ongoing efforts to help reduce the risk of cross-contamination at every touchpoint.
Historically, patients in isolation were among the most infectious and the most vulnerable to cross-contamination, but today you’re initiating precautions facility-wide to help mitigate the spread of infectious agents among and within people, instruments and devices.
3M continues to provide information, education and resources to those on the front line of the COVID-19 pandemic. You can also request your 3M representative follow-up with you for personalized support.
Hands are one the most common sources of microbial transmission. Practicing hand hygiene across all areas in a facility can help reduce the spread of microbes and patient cross-contamination.
Barrier films, cleansers and moisture management technology can help reduce the incidence of red, irritated or damaged skin and also help reduce the risk of device-related complications.
Single-use and single-patient use products can help add another line of defense against cross-contamination among people and medical equipment.
Standards and guidelines recommend the sterilization of ‘critical’ medical devices prior to use in patient procedures. A robust sterility assurance program is a critical element of device reprocessing.
Patients have a 50% chance of contracting a multi-drug resistant organism (MDRO) if the patient room is not properly cleaned.4 Consistent cleaning monitoring can also greatly decrease the risk of MDROs.5
When information and recommendations are changing rapidly, it can be difficult to keep up with the latest guidelines and protocols and ensuring that staff is trained appropriately. 3M can be an extension of your team and help deepen your facility’s expertise through professional training and educational resources designed to meet your facility’s unique challenges.
The 3M™ Peak™ Clinical Outcomes Program provides you with the resources and partnership you need to define and achieve the outcomes most important to you, your patients and your organization. We offer customized assessment tools to empower you to drive compliance by streamlining the auditing process and providing customized guidance and feedback to help define success.
We currently offer more than 40 on-demand educational courses on topics including respiratory protection, skin protection and sterilization.
After 3M aggregated 3M™ Clean-Trace™ ATP Monitoring System environmental surface testing data6, we identified the top four contaminated room surface offenders. Find out what they were and how to protect your facility in this blog post.
You’re being asked to do more with less and balance ongoing healthcare-acquired infection (HAI) initiatives with pandemic response. Whether it is trying to navigate new and changing guidelines, finding alternative product solutions or providing supplemental education to staff, 3M is here to help – both virtually and, if appropriate, in-person.
Thank you for connecting with 3M! We'll be in touch with you shortly.
An error has occurred while submitting. Please try again.
*3M solutions can play a role in supporting government and industry guidelines aimed at infection and transmission control. 3M does not make any claims that its products prevent or reduce the incidence of infection or the transmission of disease. For specific 3M products, please refer to the intended use.
1. Active bacterial core surveillance (ABCs) report: Methicillin-resistant Staphylococcus aureus, 2014. Center for Disease Control and Prevention website.
Updated April 6, 2016. Accessed November 1, 2017.
2. Lessa FC, Mu Y, Bamberg WM, et al. Burden of clostridium difficile infection in the united states. N Engl J Med. 2015;372(9):825-834.
http://dx.doi.org/10.1056/NEJMoa1408913. doi: 10.1056/NEJMoa1408913.
3. Tuberculosis (TB): Data and Statistics. Center for Disease Control and Prevention website.
https://www.cdc.gov/tb/statistics/default.htm. Updated March 22, 2018. Accessed April 18, 2018
4. Otter JA, Jezli S, Salkeld JA, et al. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. American Journal of Infection Control 2013. 41(5 Supplement):S6-11.
5. Sitzlar B, Deshpande A, Fertelli D, et al. An environmental disinfection odyssey: Evaluation of sequential interventions to improve disinfection of clostridium difficile isolation rooms. The role of the environment in Infection Prevention May 2013. Infection Control and Hospital Epidemiology 34(4):459-465. 3M data on file: EM-05-311617
6. 3M data on file. Data aggregated from the 3M™ Clean-Trace ATP Monitoring System’s ATP environmental surface testing across the United States: January 2018 - September 2019.